New York, NY (PRWEB) March 01, 2013
The birth control safety advocates at DrugRisk.com are alerting women using the IUD contraceptive Mirena of updated information on the site showing use of the devices dropped for the last part of 2012, as a court gets set to decide the fate of growing patient injury claims.
“The mission of DrugRisk is to improve consumer safety by providing the latest drug warnings, recalls, studies and legal news. Many visitors look for legal news to learn if other patients are having similar side effects and whether they need legal advice,” explains DrugRisk representative Ryan Mayer.
DrugRisk contains information showing the FDA has received more than 47,000 AERS adverse event reports for complications by patients using the Mirena IUD.* Of these, 5079 involved dislocation and 1421 involved device migration, which can damage the uterine wall or other organs.* Over 6% of patients required hospitalization or surgery.
Now, the latest financial reports from Bayer indicate sales of Mirena dropped 14% in the 4th quarter of 2012, from $206 million to $177 million, compared to the previous year.**
DrugRisk has discovered injury claims from patients may be growing as well. With the number of patients filing a Mirena lawsuit increasing, plaintiffs filed a petition for cases to be consolidated in one federal Multi-District Litigation court in Ohio.*** The petition estimates that, with more than 2 million users, hundreds of Mirena perforation cases could be filed.
DrugRisk has learned that the Joint Panel on Multi-District Litigation will conduct a hearing on March 21, 2013 to decide whether cases will be consolidated to one court, and where.****
Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal rights. Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers who are already handling Mirena lawsuits.
*FDA AERS Reports for Mirena through June 30, 2012 - drugcite.com/?q=mirena
**Bayer 2012 Annual Report Combined Management Report - Overview of Sales, Earnings and Financial Position, February 28, 2013
***In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780; harrismartin.com/media/uploads/documents/DRU-1301-27.pdf